Skip to main content
. 2024 Sep 27;22:421. doi: 10.1186/s12916-024-03637-z

Table 5.

The guidelines of PMS for CGTPs in China

Guideline Main content
1 Technical guidelines for long-term follow-up clinical studies of gene therapy products [116] Long term follow-up
2 Technical guidelines for clinical risk management plan of chimeric antigen receptor T cell (CAR-T) therapeutic products [117] Risk management
3 Guidance for writing a clinical risk management plan (for Trial Implementation) [118] Risk management
4 Guideline for pharmacovigilance examination [119] PV